iLIVER

Open Access Original Article

Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma

Ying Liu, Yaqin Wang, Zhanqi Wei, [...], Tianxiao Wang, Shizhong Yang, Canhong Xiang, Xuedong Wang, Lei Gong, Jiahong Dong, Qian Lu, Yuewei Zhang << Fewer

https://doi.org/10.1016/j.iliver.2022.01.001

Published: 07 March 2022

2022, 1 (1): 35-42

Downloads: 66 | Views: 1042 |

PDF (850.9 KB)

Open Access Review

Advances in artificial intelligence techniques drive the application of radiomics in the clinical research of hepatocellular carcinoma

Jingwei Wei, Meng Niu, Ouyang Yabo, [...], Yu Zhou, Xiaoke Ma, Xue Yang, Hanyu Jiang, Hui Hui, Hongyi Cao, Binwei Duan, Hongjun Li, Dawei Ding, Jie Tian << Fewer

https://doi.org/10.1016/j.iliver.2022.02.005

Published: 10 March 2022

2022, 1 (1): 49-54

Downloads: 27 | Views: 733 |

PDF (353.8 KB)

Open Access Review

Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?

Xun Qiu, Fengqiang Gao, Kai Wang, [...], Zhensheng Zhang, Chuxiao Shao, Xiao Xu << Fewer

https://doi.org/10.1016/j.iliver.2022.03.003

Published: 28 March 2022

2022, 1 (1): 55-64

Downloads: 36 | Views: 776 |

PDF (1.6 MB)

Open Access Review

Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management

Jia Fu, Shou-jin Cao, Li Song, [...], Xiao-qiang Tong, Jian Wang, Min Yang, Ying-hua Zou << Fewer

https://doi.org/10.1016/j.iliver.2022.07.001

Published: 01 August 2022

2022, 1 (2): 96-100

Downloads: 11 | Views: 476 |

PDF (863.2 KB)

Open Access Original Article

Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosis

Huiying Rao, Jia Shang, Qing Xie, [...], Jianqi Lian, Pujun Gao, Junping Shi, Xinyue Chen, Jiefei Wang, Min Xu, Liaoyun Zhang, Yingren Zhao, Qing Mao, Maorong Wang, Wei Zhao, Zong Zhang, Jidong Jia, Hong Tang, Jiming Zhang, Xin Zheng, Chang Liu, Lai Wei << Fewer

https://doi.org/10.1016/j.iliver.2022.08.006

Published: 12 October 2022

2022, 1 (3): 145-153

Downloads: 9 | Views: 255 |

PDF (1.3 MB)

Open Access Original Article

A retrospective study of PD-L1 immunohistochemistry for hepatocellular carcinoma

Min Du, Yumeng Cai, Yanrui Pang, Yuan Ji

https://doi.org/10.1016/j.iliver.2022.08.005

Published: 07 September 2022

2022, 1 (3): 187-193

Downloads: 12 | Views: 487 |

PDF (6.7 MB)

Open Access Original Article

Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study

Chenghao Ge, Mingjie Luo, Kaiyuan Guo, [...], Dong Zhu, Ning Han, Tengjiao Wang, Xiuying Zhao << Fewer

https://doi.org/10.1016/j.iliver.2022.11.003

Published: 23 November 2022

2022, 1 (4): 209-216

Downloads: 24 | Views: 811 |

PDF (2 MB)

Open Access Review

Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review

Jingxin Yan, Manjun Deng, Shunyu Kong, [...], Ting Li, Zhenwu Lei, Lushun Zhang, Yutong Zhuang, Xin He, Huanwei Wang, Haining Fan, Yingxing Guo << Fewer

https://doi.org/10.1016/j.iliver.2022.10.001

Published: 04 November 2022

2022, 1 (4): 225-234

Downloads: 4 | Views: 329 |

PDF (506.9 KB)

Open Access Original Article

Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis

Hao Chi, Dapeng Chen, Yuliang Zhang, [...], Zilin Cui, Yi Bai, Yamin Zhang << Fewer

https://doi.org/10.1016/j.iliver.2022.12.002

Published: 13 January 2023

2023, 2 (1): 16-25

Downloads: 38 | Views: 300 |